4 Cutting-Edge Healthcare Stocks To Buy For 2021

SGEN reported its latest financial results last week, and both earnings and revenue destroyed analyst expectations. EPS came in at $3.50 in its most recent quarter, a massive jump from a loss of $0.55 in the same quarter last year. The stock is rated a “Buy” in our POWR Ratings system, with a grade of “A” for Peer Grade and a “B” for Trade Grade. The stock is also ranked #10 in the Biotech industry.

Amedisys Inc. (AMED - Get Rating)

AMED is a healthcare services company that brings healthcare to the home by providing home healthcare services, hospice services, and personal care services. This company will undoubtedly benefit from an aging population and the growing demand for in-home health services. It is already benefiting from the pandemic as more people have been forced to receive medical care at home.

The company has also benefited from recent acquisitions of hospice care providers Asana Hospice, RoseRock Healthcare, CCH, and AseraCare. The acquisition of AseraCare, which was just completed in June, strengthened its hospice care business. AMED now offers its services at over 500 locations in the U.S.

AMED reported its earnings on Monday and beat analyst expectations for both EPS and revenue. Revenue grew by 10% to $544 million, and earnings increased by 32.2% to $1.52. Growth was led by a rebound in hospice care. The stock is rated a “Strong Buy” in our POWR Ratings system. It holds grades of “A” for Trade Grade, Buy & Hold Grade, and Peer Grade. It has a grade of “B” for the remaining POWR component, Industry Rank. AMED is ranked #2 out of 70 stocks in the Medical – Services industry.

LHC Group (LHCG - Get Rating)

LHC provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies, and long-term acute care hospitals. This stock is another play on the needs of an aging population. Similar to AMED, the company has been gaining from an increase in hospice admissions.

View single page >> |

Disclaimer: Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.